Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis N Bourdette

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Neurology|August 2, 2017
Author response: Neurologists and the economics of MS treatment: Lighting candles, not cursing the darknessDennis N Bourdette
Current Neurology and Neuroscience Reports|August 2, 2011
Cognitive impairment and MS: searching for effective therapiesVijayshree Yadav, Dennis N Bourdette
Journal of Neuroimmunology|October 24, 2006
Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitisAbigail C Buenafe, Dennis N Bourdette
Neurology|July 1, 2014
Venous angioplasty for "CCSVI" in multiple sclerosis: ending a therapeutic misadventureDennis N Bourdette, Jeffrey A Cohen
Journal of Neuroimmunology|April 29, 2006
Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitisPriya Chaudhary, Gail H Marracci, Dennis N Bourdette
JAMA Internal Medicine|April 4, 2018
Uses of H.P. Acthar Gel in the Clinical Setting-ReplyDaniel M Hartung, Dennis N Bourdette, David M Cohen
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Endocrine, Metabolic & Immune Disorders Drug Targets|June 10, 2008
Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNSSonemany Salinthone, Vijayshree Yadav, Dennis N Bourdette, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Neurology|August 2, 2017
Author response: Neurologists and the economics of MS treatment: Lighting candles, not cursing the darknessDennis N Bourdette
Current Neurology and Neuroscience Reports|August 2, 2011
Cognitive impairment and MS: searching for effective therapiesVijayshree Yadav, Dennis N Bourdette
Journal of Neuroimmunology|October 24, 2006
Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitisAbigail C Buenafe, Dennis N Bourdette
Neurology|July 1, 2014
Venous angioplasty for "CCSVI" in multiple sclerosis: ending a therapeutic misadventureDennis N Bourdette, Jeffrey A Cohen
Journal of Neuroimmunology|April 29, 2006
Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitisPriya Chaudhary, Gail H Marracci, Dennis N Bourdette
JAMA Internal Medicine|April 4, 2018
Uses of H.P. Acthar Gel in the Clinical Setting-ReplyDaniel M Hartung, Dennis N Bourdette, David M Cohen
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Endocrine, Metabolic & Immune Disorders Drug Targets|June 10, 2008
Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNSSonemany Salinthone, Vijayshree Yadav, Dennis N Bourdette, et al.
Pageof 7